Literature DB >> 11773416

Heterologous gene expression from transmissible gastroenteritis virus replicon particles.

Kristopher M Curtis1, Boyd Yount, Ralph S Baric.   

Abstract

We have recently isolated a transmissible gastroenteritis virus (TGEV) infectious construct designated TGEV 1000 (B. Yount, K. M. Curtis, and R. S. Baric, J. Virol. 74:10600-10611, 2000). Using this construct, a recombinant TGEV was constructed that replaced open reading frame (ORF) 3A with a heterologous gene encoding green fluorescent protein (GFP). Following transfection of baby hamster kidney (BHK) cells, a recombinant TGEV (TGEV-GFP2) was isolated that replicated efficiently and expressed GFP. Replicon constructs were constructed that lacked either the ORF 3B and E genes or the ORF 3B, E, and M genes [TGEV-Rep(AvrII) and TGEV-Rep(EcoNI), respectively]. As the E and M proteins are essential for TGEV virion budding, these replicon RNAs should replicate but not result in the production of infectious virus. Following cotransfection of BHK cells with the replicon RNAs carrying gfp, GFP expression was evident by fluorescent microscopy and leader-containing transcripts carrying gfp were detected by reverse transcription-PCR (RT-PCR). Subsequent passage of cell culture supernatants onto permissive swine testicular (ST) cells did not result in the virus, GFP expression, or the presence of leader-containing subgenomic transcripts, demonstrating the single-hit nature of the TGEV replicon RNAs. To prepare a packaging system to assemble TGEV replicon particles (TGEV VRP), the TGEV E gene was cloned into a Venezuelan equine encephalitis (VEE) replicon expression vector and VEE replicon particles encoding the TGEV E protein were isolated [VEE-TGEV(E)]. BHK cells were either cotransfected with TGEV-Rep(AvrII) (E gene deletion) and VEE-TGEV(E) RNA transcripts or transfected with TGEV-Rep(AvrII) RNA transcripts and subsequently infected with VEE VRPs carrying the TGEV E gene. In both cases, GFP expression and leader-containing GFP transcripts were detected in transfected cells. Cell culture supernatants, collected approximately 36 h posttransfection, were passed onto fresh ST cells where GFP expression was evident approximately 18 h postinfection. Leader-containing GFP transcripts containing the ORF 3B and E gene deletions were detected by RT-PCR. Recombinant TGEV was not released from these cultures. Under identical conditions, TGEV-GFP2 spread throughout ST cell cultures, expressed GFP, and formed viral plaques. The development of infectious TGEV replicon particles should assist studies of TGEV replication and assembly as well as facilitate the production of novel swine candidate vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773416      PMCID: PMC135785          DOI: 10.1128/jvi.76.3.1422-1434.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

2.  Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.

Authors:  T Hanke; T J Blanchard; J Schneider; C M Hannan; M Becker; S C Gilbert; A V Hill; G L Smith; A McMichael
Journal:  Vaccine       Date:  1998-03       Impact factor: 3.641

3.  Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.

Authors:  P Pushko; M Parker; G V Ludwig; N L Davis; R E Johnston; J F Smith
Journal:  Virology       Date:  1997-12-22       Impact factor: 3.616

4.  Enhancing immune responses using suicidal DNA vaccines.

Authors:  P Berglund; C Smerdou; M N Fleeton; I Tubulekas; P Liljeström
Journal:  Nat Biotechnol       Date:  1998-06       Impact factor: 54.908

5.  Functional coupling between replication and packaging of poliovirus replicon RNA.

Authors:  C I Nugent; K L Johnson; P Sarnow; K Kirkegaard
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Persistent infection promotes cross-species transmissibility of mouse hepatitis virus.

Authors:  R S Baric; E Sullivan; L Hensley; B Yount; W Chen
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Noncytopathic Sindbis virus RNA vectors for heterologous gene expression.

Authors:  E V Agapov; I Frolov; B D Lindenbach; B M Prágai; S Schlesinger; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

Authors:  M Hevey; D Negley; P Pushko; J Smith; A Schmaljohn
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

9.  Rapid, high level protein production using DNA-based Semliki Forest virus vectors.

Authors:  D P DiCiommo; R Bremner
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly.

Authors:  F Fischer; C F Stegen; P S Masters; W A Samsonoff
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

View more
  82 in total

1.  Evolved variants of the membrane protein can partially replace the envelope protein in murine coronavirus assembly.

Authors:  Lili Kuo; Paul S Masters
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis.

Authors:  Isabel Sola; José L Moreno; Sonia Zúñiga; Sara Alonso; Luis Enjuanes
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Coronaviruses as vectors: stability of foreign gene expression.

Authors:  Cornelis A M de Haan; Bert Jan Haijema; David Boss; Frank W H Heuts; Peter J M Rottier
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 4.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

5.  Role of the coronavirus E viroporin protein transmembrane domain in virus assembly.

Authors:  Ye Ye; Brenda G Hogue
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

6.  Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.

Authors:  Amy C Sims; Ralph S Baric; Boyd Yount; Susan E Burkett; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein.

Authors:  Alessio Lorusso; Nicola Decaro; Pepijn Schellen; Peter J M Rottier; Canio Buonavoglia; Bert-Jan Haijema; Raoul J de Groot
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.

Authors:  Rong Ye; Cynthia Montalto-Morrison; Paul S Masters
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Coronaviruses as vectors: position dependence of foreign gene expression.

Authors:  Cornelis A M de Haan; Linda van Genne; Jeroen N Stoop; Haukeline Volders; Peter J M Rottier
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.